Trevi Therapeutics, Inc. Common Stock
$14.41
▼ 0.27
(-1.81%)
Volume: 1,364,691
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
18
- 21d momentum -19.6%
- MA aligned bearish
- RSI 30 oversold
🎯
Pullback
67
- RSI 30 near lows
- Near lower Bollinger band
- -8.9% vs 20MA
💎
Value
58
- -29% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)29.9
MACD-0.106
MA trendBearish
ATR4.76%
21d mom.-19.6%
63d mom.-20.6%
vs 20MA-8.9%
RVOL(20)0.88×
52w low · 8
52w high · 20
-28.7% from 52-week high
20d support 14
· resistance 18
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$2.1B
PER—
PBR6.51
PSR—
EPS$-0.36
ROE-15.9%
ROA-15.5%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-34.29
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -3.61% | -19.59% | -20.61% | +22.12% | +70.13% | +21.19% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -16.51%, daily vol 2.26%. Trevi Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.